Reports for ABBVIE CORPORATION

Company Name

ABBVIE CORPORATION

Totals

Shortage reports

125
Actual shortage: 3 (2%)
Anticipated shortage: 0 (0%)
Avoided shortage: 5 (4%)
Resolved: 117 (94%)

Discontinuation Reports

13
To be discontinued: 0 (0%)
Discontinued: 10 (77%)
Reversed: 3 (23%)

Late reports

6 (4%)

Overdue reports

1 (33%)
Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ZYMAR 0.3% SOLUTION Resolved 2017-12-18 2019-09-19 33440
ZYMAR 0.3% SOLUTION Resolved 2021-08-04 2021-08-19 143639
ZYMAR 0.3% SOLUTION Resolved 2022-10-13 2022-10-28 171699
ZYMAR 0.3% SOLUTION Resolved 2023-11-14 2023-12-07 210159
ZYMAR 0.3% SOLUTION Actual shortage 2025-11-10 2025-11-12 271370

Showing 121 to 125 of 125

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ACULAR LS 0.4% SOLUTION Discontinued 2025-01-23 2025-07-19 248365
ALPHAGAN 0.2% LIQUID Reversed 2021-12-09 2023-12-14 150885
HOLKIRA PAK 50MG 12.5MG 250MG 75MG KIT TABLET Discontinued 2017-11-30 2018-08-30 31302
HUMIRA 40MG SOLUTION Discontinued 2020-06-29 2020-11-19 119141
LUPRON 5MG SOLUTION Discontinued 2022-01-31 2022-08-17 153896
MODERIBA 600MG TABLET Discontinued 2017-11-20 2018-05-07 29835
MODERIBA 200MG TABLET Discontinued 2017-11-21 2018-08-30 29907
MODERIBA 400MG TABLET Discontinued 2017-11-30 2018-08-30 31316
NORVIR 80MG SOLUTION Discontinued 2019-02-20 2019-04-01 76354
SKYRIZI 75MG SOLUTION Discontinued 2025-01-27 2025-02-06 248607
TECHNIVIE 12.5MG 75MG 50MG TABLET Discontinued 2017-11-20 2018-05-07 29839
VIBERZI 75MG TABLET Reversed 2022-03-23 2022-06-29 157156
VIBERZI 100MG TABLET Reversed 2022-03-23 2022-06-22 157159

Showing 1 to 13 of 13